中国现代应用药学2024,Vol.41Issue(16) :2176-2183.DOI:10.13748/j.cnki.issn1007-7693.20230046

益胃饮对N-甲基-N'-硝基-亚硝基胍诱导的大鼠慢性萎缩性胃炎和胃癌的疗效及机制研究

Study on the Effect and Mechanism of Yiwei Decoction in the Treatment of N-methyl-N'-nitro-N-nitrosoguanidine-induced Chronic Atrophic Gastritis Rats and Gastric Cancer Rats

费保莹 吴人照 陈璇 朱佳杰 戴关海 梅茜钰 柴可群
中国现代应用药学2024,Vol.41Issue(16) :2176-2183.DOI:10.13748/j.cnki.issn1007-7693.20230046

益胃饮对N-甲基-N'-硝基-亚硝基胍诱导的大鼠慢性萎缩性胃炎和胃癌的疗效及机制研究

Study on the Effect and Mechanism of Yiwei Decoction in the Treatment of N-methyl-N'-nitro-N-nitrosoguanidine-induced Chronic Atrophic Gastritis Rats and Gastric Cancer Rats

费保莹 1吴人照 1陈璇 1朱佳杰 1戴关海 1梅茜钰 1柴可群1
扫码查看

作者信息

  • 1. 浙江省中医药研究院,杭州 310007
  • 折叠

摘要

目的 探究益胃饮对慢性萎缩性胃炎(chronic atrophic gastritis,CAG)和胃癌的治疗作用及其潜在分子机制.方法 采用N-甲基-N'-硝基-亚硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,MNNG)不同周期灌胃分别诱导大鼠CAG和胃癌模型,益胃饮干预后观察其疗效;结合高通量测序和RT-qPCR检测MNNG诱导肿瘤大鼠胃组织及血液中的转录水平差异.结果 益胃饮显著改善MNNG诱导的大鼠CAG和肠化生,显著降低MNNG诱导的大鼠胃十二指肠瘤块质量.高通量测序和RT-qPCR验证结果显示,胃组织中Vcan、BGIG10116_2332、rno-miR-542-3p和血清中mo-miR-363-3p的表达在MNNG诱导后显著升高,而益胃饮可以明显逆转这些现象.同时益胃饮可以不同程度地降低VEGFR、HER-2等胃癌治疗靶点的表达水平.结论 益胃饮具有治疗MNNG诱导的CAG和肠化生等胃癌前病变的显著疗效,并能进一步抑制MNNG诱导的大鼠胃十二指肠肿瘤进展,其药效机制可能是通过抑制胃部Vcan、lncRNA BGIG10116_32332和mo-miR-542-3p的过表达,及抑制血液中rno-miR-363-3p的过表达.

Abstract

OBJECTIVE To explore the effect and potential molecular mechanisms of Yiwei Decoction on chronic atrophic gastritis(CAG)and gastric cancer.METHODS N-methyl-N'-nitro-N-nitrosoguanidine(MNNG)was used to induce the model of CAG/gastric precancerous lesions and gastric cancer in rats.Therapeutic effect of Yiwei Decoction after intervention was observed.High-throughput sequencing technology and RT-qPCR were used to detect the change of transcriptome in stomach and blood of MNNG-induced tumor rats.RESULTS Yiwei Decoction significantly ameliorated the MNNG-induced CAG and intestinal metaplasia in rats,and significantly reduced the weight of tumor at gastroduodenal junction.Induction of MNNG obviously increased the mRNA level of Vcan,BGIG10116_32332 and rno-miR-542-3p in rat stomach and rno-miR-363-3p in rat serum,while Yiwei Decoction reversed these change.Moreover,Yiwei Decoction could slightly reduce the expression of gastric cancer therapeutic targets including VEGFR and HER-2.CONCLUSION Yiwei Decoction is effective in the treatment of MNNG-induced CAG and intestinal metaplasia;and it can further inhibit the progression of MNNG induced gastric and duodenal tumors in rats.Its pharmacological mechanism may be achieved by inhibiting the overexpression of Vcan,lncRNA BGIG10116-32332,and mo-miR-542-3p in the stomach,as well as suppressing the overexpression of mo-miR-363-3p in the blood.

关键词

益胃饮/治未病/慢性萎缩性胃炎/胃癌前病变/胃癌/分子机制

Key words

Yiwei Decoction/preventive treatment/chronic atrophic gastritis/precancerous lesions of gastric cancer/gastric cancer/molecular mechanisms

引用本文复制引用

基金项目

国家自然科学基金项目(81703789)

浙江省中医药(中西医结合)重点学科建设项目(2017-XK-A24)

出版年

2024
中国现代应用药学
中国药学会

中国现代应用药学

CSTPCDCSCD北大核心
影响因子:0.877
ISSN:1007-7693
参考文献量26
段落导航相关论文